MicroRNAs in inflammatory lung disease - master regulators or target practice?

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Oglesby, Irene K ^a   McElvaney, Noel G ^a   Greene, Catherine M ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; MICRORNA; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; FIBROSING ALVEOLITIS; HUMAN; INNATE IMMUNITY; LUNG CANCER; LUNG FIBROSIS; NEGATIVE FEEDBACK; NONHUMAN; REVIEW; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; INFLAMMATION; LUNG; LUNG DISEASE; METABOLISM; PATHOPHYSIOLOGY;

GENE EXPRESSION REGULATION; GENE TARGETING; HUMANS; INFLAMMATION; LUNG; LUNG DISEASES; MICRORNAS;

EID: 77958533034     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-148     Document Type: Review

References (126)

1. Hao S, Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 2009, 10(3):281-288. 10.1038/ni.1699, 2775040, 19198593.
2. McCall CE, Yoza BK. Gene silencing in severe systemic inflammation. Am J Respir Crit Care Med 2007, 175(8):763-767. 10.1164/rccm.200610-1436CP, 2176094, 17255558.
3. Britten RJ, Davidson EH. Gene regulation for higher cells: a theory. Science 1969, 165(891):349-357. 10.1126/science.165.3891.349, 5789433.
4. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854. 10.1016/0092-8674(93)90529-Y, 8252621.
5. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294(5543):862-864. 10.1126/science.1065329, 11679672.
6. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294(5543):858-862. 10.1126/science.1065062, 11679671.
7. Reinhart BJ, Weinstein EG, Rhoades MW, Bartel B, Bartel DP. MicroRNAs in plants. Genes Dev 2002, 16(13):1616-1626. 10.1101/gad.1004402, 186362, 12101121.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99(24):15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
9. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K, Croce CM. MicroRNA- 29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007, 104(40):15805-15810. 10.1073/pnas.0707628104, 2000384, 17890317.
10. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 2007, 67(22):11001-11011. 10.1158/0008-5472.CAN-07-2416, 18006846.
11. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318(5858):1931-1934. 10.1126/science.1149460, 18048652.
12. Grosshans H, Filipowicz W. Molecular biology: the expanding world of small RNAs. Nature 2008, 451(7177):414-416. 10.1038/451414a, 18216846.
13. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004, 432(7014):231-235. 10.1038/nature03049, 15531879.
14. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004, 18(24):3016-3027. 10.1101/gad.1262504, 535913, 15574589.
15. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004, 23(20):4051-4060. 10.1038/sj.emboj.7600385, 524334, 15372072.
16. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 2005, 6(5):376-385. 10.1038/nrm1644, 15852042.
17. Weinmann L, Hock J, Ivacevic T, Ohrt T, Mutze J, Schwille P, Kremmer E, Benes V, Urlaub H, Meister G. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 2009, 136(3):496-507. 10.1016/j.cell.2008.12.023, 19167051.
18. Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol 2008, 20(2):214-221. 10.1016/j.ceb.2008.01.006, 18329869.
19. Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci USA 2007, 104(23):9667-9672. 10.1073/pnas.0703820104, 1887587, 17535905.
20. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010, 10(2):111-122. 10.1038/nri2708, 20098459.
21. Wiesen JL, Tomasi TB. Dicer is regulated by cellular stresses and interferons. Mol Immunol 2009, 46(6):1222-1228. 10.1016/j.molimm.2008.11.012, 2678889, 19118902.
22. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460(7254):529-533. 10.1038/nature08199, 19626115.
23. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 2009, 379(3):726-731. 10.1016/j.bbrc.2008.12.098, 19116145.
24. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007, 81(4):829-834. 10.1086/521200, 2227932, 17847008.
25. Takacs CM, Giraldez AJ. MicroRNAs as genetic sculptors: Fishing for clues. Semin Cell Dev Biol 2010,
26. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signalling and vascular integrity. Dev Cell 2008, 15(2):272-284. 10.1016/j.devcel.2008.07.008, 2604134, 18694566.
27. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008, 15(2):261-271. 10.1016/j.devcel.2008.07.002, 2685763, 18694565.
28. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451(7175):147-152. 10.1038/nature06487, 2782491, 18185580.
29. Mishima Y, Giraldez AJ, Takeda Y, Fujiwara T, Sakamoto H, Schier AF, Inoue K. Differential regulation of germline mRNAs in soma and germ cells by zebrafish miR-430. Curr Biol 2006, 16(21):2135-2142. 10.1016/j.cub.2006.08.086, 1764209, 17084698.
30. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465(7301):1033-1038. 10.1038/nature09144, 20577206.
31. Chatterjee S, Grosshans H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 2009, 461(7263):546-549. 10.1038/nature08349, 19734881.
32. Ramachandran V, Chen X. Degradation of microRNAs by a family of exoribonucleases in Arabidopsis. Science 2008, 321(5895):1490-1492. 10.1126/science.1163728, 2570778, 18787168.
33. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD. MicroRNAs: new regulators of immune cell development and function. Nat Immunol 2008, 9(8):839-845. 10.1038/ni.f.209, 18645592.
34. Lindsay MA. microRNAs and the immune response. Trends Immunol 2008, 29(7):343-351. 10.1016/j.it.2008.04.004, 18515182.
35. Nana-Sinkam SP, Hunter MG, Nuovo GJ, Schmittgen TD, Gelinas R, Galas D, Marsh CB. Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med 2009, 179(1):4-10. 10.1164/rccm.200807-1042PP, 2615660, 18787215.
36. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008, 18(2):131-140. 10.1016/j.semcancer.2008.01.005, 18291670.
37. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, Wilson CB, Brockdorff N, Fisher AG, Smale ST, Merkenschlager M. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005, 201(9):1367-1373. 10.1084/jem.20050572, 2213187, 15867090.
38. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005, 202(2):261-269. 10.1084/jem.20050678, 2212998, 16009718.
39. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci USA 2007, 104(17):7080-7085. 10.1073/pnas.0702409104, 1855395, 17438277.
40. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131(1):146-159. 10.1016/j.cell.2007.07.021, 17923094.
41. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303(5654):83-86. 10.1126/science.1091903, 14657504.
42. Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129(1):147-161. 10.1016/j.cell.2007.03.008, 17382377.
43. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska EA, Vetrie D, Okkenhaug K, Enright AJ, Dougan G, Turner M, Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316(5824):608-611. 10.1126/science.1139253, 2610435, 17463290.
44. Brennan S. Innate immune activation and cystic fibrosis. Paediatr Respir Rev 2008, 9(4):271-279. quiz 279-280, 10.1016/j.prrv.2008.05.008, 19026368.
45. Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 2007, 37(2):306-309. 10.1002/eji.200637009, 17273997.
46. O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006, 18(1):3-9. 10.1016/j.coi.2005.11.012, 16343886.
47. Takeda K, Akira S. TLR signalling pathways. Semin Immunol 2004, 16(1):3-9. 10.1016/j.smim.2003.10.003, 14751757.
48. Chotirmall SH, Greene CM, Oglesby IK, Thomas W, O'Neill SJ, Harvey BJ, McElvaney NG. 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor. Am J Respir Crit Care Med 2010, 182(1):62-72. 10.1164/rccm.201001-0053OC, 20378727.
49. Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004, 5(10):975-979. 10.1038/ni1116, 15454920.
50. Sabroe I. Toll-Like receptors in respiratory disease. Mechanisms of pulmonary innate immunity 2008, Research Signpost.
51. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007, 26(2):133-137. 10.1016/j.immuni.2007.02.005, 17307699.
52. Pedersen I, David M. MicroRNAs in the immune response. Cytokine 2008, 43(3):391-394. 10.1016/j.cyto.2008.07.016, 18701320.
53. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007, 104(5):1604-1609. 10.1073/pnas.0610731104, 1780072, 17242365.
54. Bazzoni F, Rossato M, Fabbri M, Gaudiosi D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA, Locati M. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci USA 2009, 106(13):5282-5287. 10.1073/pnas.0810909106, 2664036, 19289835.
55. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci USA 2009, 106(17):7113-7118. 10.1073/pnas.0902636106, 2678424, 19359473.
56. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, Johnson DS, Chen Y, O'Neill LA. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010, 11(2):141-147. 10.1038/ni.1828, 19946272.
57. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signalling proteins of innate immune responses. Proc Natl Acad Sci USA 2006, 103(33):12481-12486. 10.1073/pnas.0605298103, 1567904, 16885212.
58. Blumenthal MN, Langefeld CD, Barnes KC, Ober C, Meyers DA, King RA, Beaty TH, Beck SR, Bleecker ER, Rich SS. A genome-wide search for quantitative trait loci contributing to variation in seasonal pollen reactivity. J Allergy Clin Immunol 2006, 117(1):79-85. 10.1016/j.jaci.2005.09.038, 16387588.
59. Ober C, Cox NJ, Abney M, Di Rienzo A, Lander ES, Changyaleket B, Gidley H, Kurtz B, Lee J, Nance M, Pettersson A, Prescott J, Richardson A, Schlenker E, Summerhill E, Willadsen S, Parry R. Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet 1998, 7(9):1393-1398. 10.1093/hmg/7.9.1393, 9700192.
60. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007, 282(39):28929-28938. 10.1074/jbc.M702633200, 2194650, 17660297.
61. Murphy AJ, Guyre PM, Pioli PA. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol 2010, 184(9):5029-5037. 10.4049/jimmunol.0903463, 20351193.
62. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31(2):220-231. 10.1016/j.immuni.2009.06.024, 2865583, 19699171.
63. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5(6):446-458. 10.1038/nri1630, 15928677.
64. Greene CM, Branagan P, McElvaney NG. Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opin Ther Targets 2008, 12(12):1481-1495. 10.1517/14728220802515293, 19007318.
65. Suarez Y, Wang C, Manes TD, Pober JS. Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol 2010, 184(1):21-25. 10.4049/jimmunol.0902369, 19949084.
66. McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, Murray PJ, O'Neill LA. IL-10 inhibits miR-155 induction by toll-like receptors. J Biol Chem 2010, 285(27):20492-20498. 10.1074/jbc.M110.102111, 20435894.
67. Perry MM, Moschos SA, Williams AE, Shepherd NJ, Larner-Svensson HM, Lindsay MA. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 2008, 180(8):5689-5698. 2639646, 18390754.
68. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000, 248(3):171-183. 10.1046/j.1365-2796.2000.00742.x, 10971784.
69. Lin Y, Bai L, Chen W, Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 2010, 14(1):45-55. 10.1517/14728220903431069, 20001209.
70. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64(11):3753-3756. 10.1158/0008-5472.CAN-04-0637, 15172979.
71. Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K, Omotola M, Homer R, Brown D, Bader AG, Weidhaas JB, Slack FJ. Regression of murine lung tumors by the let-7 microRNA. Oncogene 2010, 29(11):1580-1587. 10.1038/onc.2009.445, 2841713, 19966857.
72. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833. 10.1038/nature03552, 15944707.
73. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132(5):875-886. 10.1016/j.cell.2008.02.019, 2323338, 18329372.
74. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005, 65(21):9628-9632. 10.1158/0008-5472.CAN-05-2352, 16266980.
75. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 2009, 66:169-175. 10.1016/j.lungcan.2009.01.010, 19223090.
76. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Li KC, Chen JJ, Yang PC. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13(1):48-57. 10.1016/j.ccr.2007.12.008, 18167339.
77. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, Fang H, Zhang J, Katz RL, Jiang F. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010,
78. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105(30):10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
79. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010, 16(2):610-619. 10.1158/1078-0432.CCR-09-2638, 20068099.
80. Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008, 300(20):2407-2416. 10.1001/jama.2008.717, 19033591.
81. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163(5):1256-1276.
82. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349(9064):1498-1504. 10.1016/S0140-6736(96)07492-2, 9167458.
83. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, Mannino D, Wouters E, Sethi S, Cooper CB. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention. COPD 2008, 5(4):235-256. 10.1080/15412550802237531, 18671149.
84. Oudijk EJ, Gerritsen WB, Nijhuis EH, Kanters D, Maesen BL, Lammers JW, Koenderman L. Expression of priming-associated cellular markers on neutrophils during an exacerbation of COPD. Respir Med 2006, 100(10):1791-1799. 10.1016/j.rmed.2006.01.022, 16531033.
85. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2009, 23(3):806-812. 10.1096/fj.08-121384, 2653990, 18952709.
86. Izzotti A, Calin GA, Steele VE, Croce CM, De Flora S. Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 2009, 23(9):3243-3250. 10.1096/fj.09-135251, 2735372, 19465468.
87. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Bowers J, Vaziri C, Ott K, Sensinger K, Collins JJ, Brody JS, Getts R, Lenburg ME, Spira A. MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci USA 2009, 106(7):2319-2324. 10.1073/pnas.0806383106, 2650144, 19168627.
88. Jardim MJ, Fry RC, Jaspers I, Dailey L, Diaz-Sanchez D. Disruption of microRNA expression in human airway cells by diesel exhaust particles is linked to tumorigenesis-associated pathways. Environ Health Perspect 2009, 117(11):1745-1751. 2801177, 20049127.
89. Masoli M, Beasley R. Asthma exacerbations and inhaled corticosteroids. Lancet 2004, 363(9416):1236. 10.1016/S0140-6736(04)15961-8, 15081663.
90. Miller RL, Ho SM. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008, 177(6):567-573. 10.1164/rccm.200710-1511PP, 2267336, 18187692.
91. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993, 92(2):313-324. 10.1016/0091-6749(93)90175-F, 8349942.
92. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999, 17:255-281. 10.1146/annurev.immunol.17.1.255, 10358759.
93. Seguin RM, Ferrari N. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 2009, 18(10):1505-1517. 10.1517/13543780903179294, 19715448.
94. Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 2009, 182(8):4994-5002. 10.4049/jimmunol.0803560, 19342679.
95. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998, 16:495-521. 10.1146/annurev.immunol.16.1.495, 9597139.
96. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3(2):133-146. 10.1038/nri1001, 12563297.
97. Chiba Y, Tanabe M, Goto K, Sakai H, Misawa M. Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells. Am J Respir Crit Care Med 2009, 180(8):713-719. 10.1164/rccm.200903-0325OC, 19644046.
98. Chiba Y, Takada Y, Miyamoto S, MitsuiSaito M, Karaki H, Misawa M. Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats. Br J Pharmacol 1999, 127(3):597-600. 10.1038/sj.bjp.0702585, 1566055, 10401547.
99. Chiba Y, Ueno A, Shinozaki K, Takeyama H, Nakazawa S, Sakai H, Misawa M. Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice. Respir Res 2005, 6:4. 10.1186/1465-9921-6-4, 545934, 15638941.
100. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM, Erjefalt JS, Chung KF, Lindsay MA. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009, 4(6):e5889. 10.1371/journal.pone.0005889, 2690402, 19521514.
101. World Health Organization and Cystic Fibrosis Associations Worldwide The molecular genetic epidemiology of cystic fibrosis. Report of a joint meeting of WHO/ECFTN/ICF(M)A/ECFS. World Health Organization and Cystic Fibrosis Associations Worldwide., http://www.who.int/genomics/publications/en/HGN_WB_04.02_report.pdf
102. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168(8):918-951. 10.1164/rccm.200304-505SO, 14555458.
103. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245(4922):1073-1080. 10.1126/science.2570460, 2570460.
104. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245(4922):1066-1073. 10.1126/science.2475911, 2475911.
105. Kreindler JL. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies. Pharmacol Ther 2010, 125(2):219-229. 10.1016/j.pharmthera.2009.10.006, 19903491.
106. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005, 352(19):1992-2001. 10.1056/NEJMra043184, 15888700.
107. Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'Neill SJ, McElvaney NG. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol 2005, 174(3):1638-1646.
108. Carroll TP, Greene CM, Taggart CC, Bowie AG, O'Neill SJ, McElvaney NG. Viral inhibition of IL-1- and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells. J Immunol 2005, 175(11):7594-7601.
109. Griese M, Kappler M, Gaggar A, Hartl D. Inhibition of airway proteases in cystic fibrosis lung disease. Eur Respir J 2008, 32(3):783-795. 10.1183/09031936.00146807, 18757703.
110. Taggart CC, Greene CM, Carroll TP, O'Neill SJ, McElvaney NG. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am J Respir Crit Care Med 2005, 171(10):1070-1076. 10.1164/rccm.200407-881PP, 15695494.
111. Walsh DE, Greene CM, Carroll TP, Taggart CC, Gallagher PM, O'Neill SJ, McElvaney NG. Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium. J Biol Chem 2001, 276(38):35494-35499. 10.1074/jbc.M103543200, 11461907.
112. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG, Greene CM. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 2010, 184(4):1702-1709. 10.4049/jimmunol.0902669, 20083669.
113. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA 2008, 105(5):1516-1521. 10.1073/pnas.0707493105, 2234176, 18227515.
114. Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam SP. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008, 373(4):607-612. 10.1016/j.bbrc.2008.06.090, 18602365.
115. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11(3):241-247. 10.1261/rna.7240905, 1370713, 15701730.
116. Wang Y, Weng T, Gou D, Chen Z, Chintagari NR, Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics 2007, 8:29. 10.1186/1471-2164-8-29, 1790902, 17250765.
117. Brissoni B, Agostini L, Kropf M, Martinon F, Swoboda V, Lippens S, Everett H, Aebi N, Janssens S, Meylan E, Felberbaum-Corti M, Hirling H, Gruenberg J, Tschopp J, Burns K. Intracellular trafficking of interleukin-1 receptor I requires Tollip. Curr Biol 2006, 16(22):2265-2270. 10.1016/j.cub.2006.09.062, 17113392.
118. Katoh Y, Shiba Y, Mitsuhashi H, Yanagida Y, Takatsu H, Nakayama K. Tollip and Tom1 form a complex and recruit ubiquitin-conjugated proteins onto early endosomes. J Biol Chem 2004, 279(23):24435-24443. 10.1074/jbc.M400059200, 15047686.
119. Yamakami M, Yoshimori T, Yokosawa H. Tom1, a VHS domain-containing protein, interacts with tollip, ubiquitin, and clathrin. J Biol Chem 2003, 278(52):52865-52872. 10.1074/jbc.M306740200, 14563850.
120. Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci USA 2009, 106(44):18704-18709. 10.1073/pnas.0905063106, 2773983, 19843690.
121. Brunner C, Sindrilaru A, Girkontaite I, Fischer KD, Sunderkotter C, Wirth T. BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses. EMBO J 2007, 26(13):3191-3202. 10.1038/sj.emboj.7601742, 1914090, 17568779.
122. Lichtinger M, Ingram R, Hornef M, Bonifer C, Rehli M. Transcription factor PU.1 controls transcription start site positioning and alternative TLR4 promoter usage. J Biol Chem 2007, 282(37):26874-26883. 10.1074/jbc.M703856200, 17623651.
123. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009, 4(8):e6718. 10.1371/journal.pone.0006718, 2726943, 19701459.
124. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010, 182(2):220-229. 10.1164/rccm.200911-1698OC, 20395557.
125. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010, 207(8):1589-1597. 10.1084/jem.20100035, 20643828.
126. Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, Buckstein R, Lam W, Humphries RK, Karsan A. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 2010, 16(1):49-58. 10.1038/nm.2054, 19898489.